RADIOLOGY 润色咨询

RADIOLOGY

出版年份：暂无数据 年文章数：3286 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2025-06-21 ms7000001595944490 来自广东省

    审稿速度:2.0
    偏重的研究方向：MRI序列;肿瘤;乳腺
    经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2025-05-06 ms.53 来自北京

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向：胸部
    经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2025-04-25 1471d025m20暂无昵称 来自广东省

    有大修后被拒稿重投过的朋友吗？重投还有机会吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2022-01-16 ms8000000688492745

    请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2022-05-31 Furion

    精彩评论，需要您登录查看

    7

  6. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2023-05-05 1246e544m50暂无昵称 来自重庆

    请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2023-06-27 12580a75m12暂无昵称 来自江苏省

    送审后被拒的概率有多大啊

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2023-05-21 12460fc7m11(暂无昵称)

    偏重的研究方向：MRI序列;影像;影像学
    经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2019-05-13 huangxiujuan0223

    请问收case吗？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2270272, encodeId=a7b622e027274, content=审稿速度:2.0<br>偏重的研究方向：MRI序列;肿瘤;乳腺<br>经验分享：中稿分享：乳腺癌影像组研究 2024.10月下旬：manuscript投稿 2024.12月中旬：编辑给了大修，三个月时间，两个审稿人，一共40几条意见，意见中肯，需要大改 2025年4月中旬：因工作量大，延期了一个月修回，R1 2025年6月中旬：两个审稿人都同意发表，编辑发了邮件预接收，需进行格式小修，要求14天修回 2025.6中旬：只过了三天，正式接收，感谢RADIOLOGY编辑的效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9718759250, createdName=ms7000001595944490, createdTime=Sat Jun 21 09:37:48 CST 2025, time=2025-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2263747, encodeId=33412263e4708, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向：胸部<br>经验分享：有accept的大佬吗？一般多久要提交完所有作者的贡献等表格后才能开始审核吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bec65569576, createdName=ms.53, createdTime=Tue May 06 20:35:47 CST 2025, time=2025-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2262196, encodeId=8adc22621962e, content=有大修后被拒稿重投过的朋友吗？重投还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=994d5192408, createdName=1471d025m20暂无昵称, createdTime=Fri Apr 25 09:54:42 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1184841, encodeId=78d4118484100, content=请问一下，投出去的稿件一直在under review的状态 怎么知道有没有送外审啊？第一次投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1007, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=de2c5492830, createdName=ms8000000688492745, createdTime=Sun Jan 16 15:03:54 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223578, encodeId=c38e12235e888, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：最近看到一篇感兴趣的文章又写了一篇，希望这次快点见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1350, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220531/893da127e64f4d088dcab30e3c554893.jpeg, type=image, width=828, height=220)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Tue May 31 12:25:03 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130333, encodeId=308a21303330c, content=请问，radiology是先送审？还是先填了 disclosure和copyright这些后再送审啊？哪位大神科普一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82192487032, createdName=1246e544m50暂无昵称, createdTime=Fri May 05 23:08:56 CST 2023, time=2023-05-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2145094, encodeId=b300214509417, content=送审后被拒的概率有多大啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e22570281, createdName=12580a75m12暂无昵称, createdTime=Tue Jun 27 22:18:58 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2138195, encodeId=d5b2213819505, content=偏重的研究方向：MRI序列;影像;影像学<br>经验分享：想问一下各位老师，关于影像上比较小众方向的小样本研究投radiology会很容易被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e902482885, createdName=12460fc7m11(暂无昵称), createdTime=Sun May 21 15:18:07 CST 2023, time=2023-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570853, encodeId=5ae75e085388, content=请问收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f141442415, createdName=huangxiujuan0223, createdTime=Mon May 13 00:00:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105897, encodeId=7580210589e2e, content=想问一下，Radiology如果被拒了，还能接着投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=810, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a48477481, createdName=ms4000001900471414, createdTime=Tue Dec 13 20:21:30 CST 2022, time=2022-12-13, status=1, ipAttribution=山东省)]
    2022-12-13 ms4000001900471414 来自山东省

    想问一下，Radiology如果被拒了，还能接着投吗

    1

    展开1条回复
共70条页码: 1/7页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分